Sign in
4

Changes in Ownership

Alaunos Therapeutics, Inc. Filed Acc 0001209191-18-000972

COO, CLO, and Secretary gave up 53,117 shares (to pay taxes)

  • COO, CLO, and Secretary acquired 87,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
BELBEL CAESAR J COO, CLO, and Secretary 2017-12-29 Grant or award +87,000 260,551 D
BELBEL CAESAR J COO, CLO, and Secretary 2017-12-30 Shares withheld for taxes −31,450 $4.14 $130,203 229,101 D
BELBEL CAESAR J COO, CLO, and Secretary 2017-12-31 Shares withheld for taxes −21,667 $4.14 $89,701 207,434 D
Loading xslF345X03/doc4.xml…